Reportlinker Adds Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)
NEW YORK, April 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)
The Gastroesophageal Reflux Disease (GERD) Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. A review of causes and concomitant diseases and conditions are also presented. Dosing and treatment cost information is provided for various treatment types. General information on the GERD market, as well as sales of leading drugs and therapies are provided.
Table of contents
Overview
Overview of the condition
Prevalence
Prevalence Table: GERD (US, Brazil, England, Germany, Sweden, Japan, China,
Australia, Western Countries, East Asia, Worldwide)
Diagnosis
example of diagnosis criteria and diagnostic tests
Treatment
Overview
Lifestyle Changes
Antacids
H2 Receptor Antagonists
Proton Pump Inhibitors
Prokinetics
Surgery
Dosing and Treatment Costs
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs
Market Size
Overall market size
Sales information for key pharmaceuticals
Comments
References/Resources
To order this report:
: Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article